0000827054-26-000009
SEC filingMicrochip's December 2025 quarter showed a strong 15.6% YoY revenue recovery driven by inventory normalization and new design wins.
Microchip Technology reported a strong recovery in the December 2025 quarter, with net sales of $1.186 billion, up 15.6% year-over-year from $1.026 billion in the same period last year. The increase was primarily driven by customers working through excess inventory levels and new customer design win activity coming to production. For the nine-month period, net sales were $3.402 billion, down slightly (0.9%) from $3.431 billion in the prior year, reflecting the lingering effects of the inventory correction that persisted through the first half of fiscal 2026.
Gross profit improved significantly to $706.9 million (59.6% of net sales) in Q3 FY26, compared to $561.4 million (54.7% of net sales) in Q3 FY25. The 490 basis point gross margin expansion was driven by favorable product mix (including higher sales of networking, data center, and FPGA products), higher licensing revenue, and lower inventory reserves. Unabsorbed capacity charges had an unfavorable impact of $9.1 million in the quarter, while inventory reserve charges provided a favorable impact of $34.6 million. Licensing revenue, which carries no associated cost of sales, contributed a favorable $27.9 million impact.
Operating income surged to $151.9 million (12.8% of net sales) from $30.8 million (3.0% of net sales) in the prior year quarter, reflecting the strong gross margin improvement and operating leverage. Net income for the nine-month period was $85.8 million, down from $154.1 million in the prior year, impacted by higher special charges and restructuring costs.
Mixed-signal microcontrollers, the largest product line, generated $586.5 million in Q3 FY26 revenue (49.5% of total), up 10.0% YoY. The analog product line grew 18.4% YoY to $322.9 million (27.2% of total), benefiting from customers replenishing inventory after working through high balances. The 'Other' category, which includes FPGA, royalties, and IP sales, grew 25.7% YoY to $276.6 million, primarily due to sales of certain intellectual property rights.
Geographically, net sales increased in all regions in Q3 FY26 compared to the prior year quarter. Americas sales grew to $366.7 million (30.9% of total), Europe to $246.2 million (20.8%), and Asia to $573.1 million (48.3%). The sequential improvement was broad-based, with Americas and Europe up sequentially and Asia essentially flat.
Management's outlook reflects cautious optimism. The company expects inventory levels to continue declining over the next several quarters as it executes its recovery plan. Capital expenditures are expected to be at or below $100 million over the next 12 months, with most factory expansion paused. The company believes current inventory and production capacity are adequate to fulfill projected customer requirements.
Key strategic priorities include continuing to invest in new and enhanced products, maintaining manufacturing control through owned facilities, and selectively transitioning outsourced assembly and test capacity to internal facilities. The company also noted the potential for CHIPS Act grants of $162 million for two U.S. wafer fabrication facilities, though negotiations are ongoing and final approval is not guaranteed.
Cash and cash equivalents stood at $250.7M at December 31, 2025, down from $771.7M at March 31, 2025, primarily due to debt repayments and dividend payments. Total debt (net) decreased to $5,366.0M from $5,630.4M, reflecting the repayment of $1.2B in 4.250% 2025 Notes, partially offset by a $931M increase in Commercial Paper outstanding. Shareholders' equity declined to $6,560.4M from $7,078.3M, driven by dividends and net income. Inventory decreased to $1,057.7M from $1,293.5M, a reduction of 18.2%, indicating ongoing inventory normalization.
Total purchase commitments were $430.0M as of December 31, 2025, primarily for wafer purchase obligations and manufacturing supply capacity reservations. Of this, $194.8M is due within one year (fiscal 2026), $172.8M in the next one to three years (fiscal 2027-2028), and $62.4M beyond three years. Deferred revenue, representing customer deposits and advance payments, totaled $345.0M, down significantly from $597.9M at March 31, 2025, reflecting revenue recognition on prior long-term supply agreements.
No common stock repurchases occurred during the three or nine months ended December 31, 2025, leaving $1.56B available under the Board-authorized repurchase program. Common dividends remained stable at $0.455 per share quarterly, totaling $737.4M for the nine months. Preferred dividends (Series A) were $27.8M per quarter, aggregating $80.7M for the nine months. Capital expenditures were $76.9M for the nine months, down from $111.8M year-over-year, representing 2.26% of net sales. The company managed debt by reducing senior notes and increasing commercial paper, resulting in a net debt decrease.
The company operates two segments: semiconductor products and technology licensing. For the three months ended December 31, 2025, semiconductor products generated $1,127.1M in net sales (95% of total) with a gross profit of $648.0M (57.5% margin), while technology licensing contributed $58.9M (5% of total) with a 100% gross margin. Year-over-year, semiconductor sales grew 13.3% and licensing surged 89.9%. No geographic mix data was provided in the Notes.
Operating cash flow of $705.1M exceeded net income of $85.8M by a wide margin, reflecting strong non-cash add-backs (depreciation & amortization of $515.6M, share-based compensation of $187.1M) and a net working capital benefit of $87.9M (driven by a $240.0M inventory decrease partially offset by a $40.9M increase in receivables and a $167.5M income tax payable decline). Capex of $76.9M was 10.9% of operating cash flow, indicating low capital intensity. Free cash flow (CFO minus capex) was $628.2M, covering dividends of $818.1M by 77%, implying a reliance on financing or cash reserves. The company did not repurchase any common stock during the period. A notable anomaly is the large swing in income tax payable (-$167.5M vs. +$6.5M prior), which reduced operating cash flow. Overall, cash generation remains solid, but capital returns exceed internally generated free cash flow.